Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Christopher Gilfillan

Adjuct Clinical Professor

MONASH UNIVERSITY

Australia

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

20%

Clinical Nutrition

40%

Diabetology

60%

Insulin Resistance

20%

Antiretroviral Therapy

10%

Evidence-based Medicine

10%

Retrovirology

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles9

Understanding the hidden epidemic of metabolic syndrome in people accessing community rehabilitation: a cross-sectional study of physical activity, dietary intake, and health literacy

Article Link

Year:

2023

Physician-Authored Feedback in a Type 2 Diabetes Self-management App: Acceptability Study

Article Link

Year:

2022

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

Article Link

Year:

2022

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women.

Article Link

Year:

2022

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Article Link

Year:

2021

Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.

Article Link

Year:

2021

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

Article Link

Year:

2021

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

Article Link

Year:

2020

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Article Link

Year:

2020

Collaborators5

Bernard Champion

Macquarie University

AUSTRALIA

Nora Shields

AUSTRALIA

Judi Porter

MONASH UNIVERSITY

AUSTRALIA

SANTIAGO TOFÉ

Profesor Asociado

University of the Balearic Islands

SPAIN

Tian Yu Goh

MONASH UNIVERSITY

AUSTRALIA

How do I reach out?

Meet Kite AI

Christopher Gilfillan

Adjuct Clinical Professor

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles9

Understanding the hidden epidemic of metabolic syndrome in people accessing community rehabilitation: a cross-sectional study of physical activity, dietary intake, and health literacy

Physician-Authored Feedback in a Type 2 Diabetes Self-management App: Acceptability Study

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women.

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Real-world﻿ artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Collaborators5

Bernard Champion

Nora Shields

Judi Porter

SANTIAGO TOFÉ

Tian Yu Goh

How do I reach out?

Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.